Animal Model Market Size, Trends, Industry Analysis by 2027

Market Highlights

Demand for animal models has increased considerably due to an increase in the use of the CRISPR technique. Due to the affordability of tools and resources relating to CRISPR technology, There has been an increase in demand for animal models from a greater number of research institutions and well-established players in the industry in developed countries. An increasing number of pharmaceutical research and development activities in emerging regions would boost the animal model’s sales to the industry. In developing countries, pharmaceutical companies are focusing on R&D activities for the production of novel drugs in order to meet the demand of healthcare professionals and patients for drugs. Pharmaceutical companies are also focusing on the production of animal models for rare diseases such as cardiomyopathy and osteoarthritis, in collaboration with several other organisations. These trends have resulted in increased demand for animal models and acceptance of them.

The growth of the global market for animal models is driven by various factors such as the increasing use of new treatment methods in biomedical research, the understanding of biocompatibility during drug development, and the cellular responsiveness of implants at an early stage. Because of all these factors, the demand for animal models in the healthcare sector is growing. Market growth is boosted by increasing innovation and research activity using the mouse model for immune diseases, cancer, rare diseases, and other research activities.

Market Overview

Animal Model Market size is expected to hold a value of about USD 3,632.48 Million by 2027 and is projected to register a CAGR of 7.8% from 2020 to 2027.

Segmental Analysis

Based on animal type, technology, application, and end-users, the worldwide animal model market has been segmented.

The global market for animal models has been segmented into pigs, mice, rats, rabbits, and others based on the animal type. Across the forecast period, the rat segment is expected to hold the maximum market share. During the assessment period, the rabbit segment is expected to be the fastest-growing. The market is segmented on the basis of technology, into CRISPR and other technologies. The market has been segmented into microinjection and electroporation, based on CRISPR.

Based on the application, the market is segmented by R&D, production and quality control. Cardiovascular, infectious diseases, metabolic diseases, immunological diseases, cancer, diabetes, genetic diseases, neurological diseases and others have been further sub-segmented in research and development.

The industry is segmented into research institutes, teaching institutes, pharmaceutical firms and contract research organisations on the basis of end-users.

Regional Overview

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Due to the presence of a large number of companies providing animal models, such as Crown Bioscience Inc., Envigo, Harbor Antibodies Bv, and many more, the Americas is expected to be the largest market. The increasing demand for the use of non-human models in scientific research is also contributing to the growing market for animal models in this region.

Market growth in this region is driven by the increasing preference for animal models for research activities and the growing number of healthcare companies (Merck KGaA, GenOway S.A., Horizon Discovery, among others). The Middle East & Africa market for animal models has been split into the Middle East and Africa. In this region, the increasing number of research laboratories drives the market growth.

Competitive Landscape

Some of the key players in the global animal model market are Janvier Labs (France), GenOway S.A. (France), Envigo (US), Charles River Laboratories (UK), Taconic Laboratories (UK),  Transgenic, Inc. (Japan), SAGE Labs (US), Horizon Discovery (England),  Crown Bioscience Inc. (US), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed)  (Massachusetts) and many more.